- Amanda Unsworth, Manchester Metropolitan University, UK
Investigating the contribution of novel regulators of the endothelium and coagulation to venous thrombosis - Pavan Bendapudi, Beth Israel Deaconess Medical Center, US
Coagulation Factor XII Is Activated via Noncanonical Binding to Platelet Integrin αIIbβ3 - Olga Oleshko, Hannover Medical School, Germany
Immune complexes and bleeding in acquired hemophilia A - Sneha Singh, University Hospital Bonn, Germany
Unraveling proteome dynamics within the human fibrin clot - Dino Mehic, Medical University of Vienna, Austria
Investigation of plasmin generation in patients with mild bleeding disorders and bleeding disorders of unknown cause
![Professor Heimburger Award](https://www.csl.com/-/media/shared/heimburger-award/heimburgergeneric.jpg?h=450&iar=0&w=1600&cropregion=0,93,1600,544&hash=6CC7D7E8D309E5FF65C517DDE6247100)
Professor Heimburger Award
Celebrating Science
Professor Dr. Norbert Heimburger, a CSL employee for over three decades, was a pioneer of modern coagulation therapy. Among his many achievements, Prof. Dr. Heimburger developed virus-safe plasma products based on pasteurization, including launching the first effectively virus-inactivated FVIII concentrate in 1981.
In his honor, CSL created the Heimburger Award to recognize the clinical and/or preclinical research of emerging coagulation specialists who are driven to improve the care of patients with bleeding disorders.